Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues to expand its extensive intellectual property portfolio through the recent filing of 3 additional US patent applications and 1 international (Patent Cooperation Treaty or "PCT") application. Canntab's portfolio now includes 11 patent applications in the United States and internationally. These filings, which include 7 non-provisional US patent application and 4 PCT patent applications, build on Canntab's growing intellectual property portfolio, which already included 7 provisional US patent applications and 10 trademark applications in the United States and Canada.

About 63 per cent of the licensed medical cannabis producers surveyed said they’d “very likely” seek American venture capital compared with 23 per cent who would "very likely" seek Canadian venture capital.

Canadian cannabis companies are hungry for U.S. private investment, according to a survey conducted by Statistics Canada looking at the state of the marijuana industry.

Dixie Brands Inc., a U.S. maker of marijuana beverages, is considering an initial public offering toward the end of this year or early next year as it seeks capital for expansion and acquisitions. The company, which hasn’t mandated bankers yet, is eyeing a listing in Canada, Chief Executive Officer Chuck Smith said Thursday in an interview on the sidelines of the Cannabis Invest U.K. conference in London. Dixie will have about $20 million in revenue this year and up to about $50-million in 2019, Smith said. “We need access to capital, we need liquidity because this growth is very expensive,” said Smith, who founded the company in 2009 and remains its majority shareholder. “We’re going to continue to acquire brands or innovate them.”

In case you haven’t noticed, the legal marijuana movement is creating quite the buzz on Wall Street. Since the start of 2016, a number of the largest pot companies by market cap have seen their share prices rise by more than 1,000%.

It has to do with a combination of rapidly growing sales, a consistent shift in the public’s opinion on cannabis, and a “marijuana first” expected out of Canada later this year.

But it’s not just sales growth that has investors excited. It’s the shift in consumer opinion toward cannabis.  With the public strongly behind the idea of legalization, investors expect sales growth throughout North America to continue climbing.

Investing in Canadian marijuana stocks two years ago would have been a dream for most investors.

INDIVA Limited (the "Company" or "INDIVA") (TSX- V:NDVA) is pleased to announce an exclusive license agreement with, and a USD $1.5 million investment into DeepCell Industries ("DeepCell"), a Seattle based technology development company focusing on material science, microfluidics and cannabinoid molecule discoveries.

DeepCell commercializes products by licensing its technology and trademarks to licensees with appropriate cannabis production and distribution licenses.

Exclusive License

In a much friendlier regulatory environment than the United States, new Canadian cannabis companies are already going international in a big way.

North of the border, cannabis was legalized nationwide in Canada, and the legal sale of cannabis is imminent, while in the United States a patchwork of state-level marijuana laws and a strongly anti-cannabis attorney general complicate business.

With an expected $22.6 billion market projected in Canada alone, Canadian companies already have a significant head start, and that could be just the beginning as they take their operations abroad.

Whether you want to wake up or chill out, these five tinctures will help you embrace the holistic qualities of cannabis to the fullest — without having to get stoned!

Until recently, cannabis tinctures have occupied an unnecessarily obscure corner of the weed world. Made by decarboxylating plant matter, then concentrating the THC/CBD in a base of oil, glycerin, or ethanol, these miracle potions — enjoyed either topically or through oral consumption — are the perfect method of intake for anyone hoping to reap the medicinal benefits of cannabis without drawbacks like smoke inhalation and smelling like pot.

A few weeks ago, Sam Houston, a California cannabis aficionado, was checking out some of his favorite YouTube channels when he noticed a trend.

One by one, accounts such as those run by users “Vader OG” and the horticulturalist known as Jorge Cervantes were being shut down. All were given the same ominous message: The channel’s content had been flagged for review and was found to violate YouTube’s guidelines.

Cannabis use is usually thought to impair our ability to pay attention or organize efficiently (and a lot of scientific research backs up that assumption to some extent). But there are also plenty of people who say smoking up helps them focus and get things done, writes Calvin Hughes.

Addiction psychiatrist Larissa Mooney says she hears this a lot.

The medical marijuana system in Canada makes it so that any patient anywhere in the country always has easy access to the drugs they need, but what about those same patients in the USA?

If you’re a medical marijuana patient in Canada, you probably have little to no trouble accessing your medication.

In Canada, patients order their medical marijuana via online services and usually LP’s websites.

In the US, the situation is a bit different since medical marijuana is only legal in some states, and only to a certain extent in others.

The difference in illnesses that fall under the category of “treatable with medical marijuana” is significant from one state to another.